World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
126
Citations
52480
World Ranking
2988
National Ranking
1655

Psychology

D-Index
124
Citations
51761
World Ranking
219
National Ranking
139

Neuroscience

D-Index
126
Citations
52480
World Ranking
317
National Ranking
190

James T. McCracken publication distribution in Psychology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Psychology in 2026. The highlighted bar marks where James T. McCracken sits on this spectrum.

31–40 publications: 6 scientists 41–50 publications: 52 scientists 51–60 publications: 138 scientists 61–70 publications: 299 scientists 71–80 publications: 461 scientists 81–90 publications: 605 scientists 91–100 publications: 713 scientists 101–110 publications: 736 scientists 111–120 publications: 686 scientists 121–130 publications: 670 scientists 131–140 publications: 644 scientists 141–150 publications: 597 scientists 151–160 publications: 576 scientists 161–170 publications: 477 scientists 171–180 publications: 450 scientists 181–190 publications: 397 scientists 191–200 publications: 343 scientists 201–210 publications: 328 scientists 211–220 publications: 313 scientists 221–230 publications: 283 scientists 231–240 publications: 226 scientists 241–250 publications: 196 scientists 251–260 publications: 201 scientists 261–270 publications: 171 scientists 271–280 publications: 151 scientists 281–290 publications: 139 scientists 291–300 publications: 113 scientists 301–310 publications: 102 scientists 311–320 publications: 100 scientists 321–330 publications: 76 scientists 331–340 publications: 92 scientists 341–350 publications: 85 scientists 351–360 publications: 69 scientists 361–370 publications: 71 scientists 371–380 publications: 63 scientists 381–390 publications: 58 scientists 391–400 publications: 57 scientists 401–410 publications: 43 scientists 411–420 publications: 33 scientists 421–430 publications: 50 scientists 431–440 publications: 41 scientists 441–450 publications: 32 scientists 451–460 publications: 27 scientists 461–470 publications: 28 scientists 471–480 publications: 25 scientists 481–490 publications: 28 scientists 491–500 publications: 20 scientists 501–510 publications: 23 scientists 511–520 publications: 26 scientists 521–530 publications: 17 scientists 531–540 publications: 21 scientists 541–550 publications: 14 scientists 551–560 publications: 16 scientists 561–570 publications: 10 scientists 571–580 publications: 22 scientists 581–590 publications: 9 scientists 591–600 publications: 14 scientists 601–610 publications: 9 scientists 611–620 publications: 11 scientists 621–630 publications: 4 scientists 631–640 publications: 7 scientists 641–650 publications: 5 scientists 651–660 publications: 10 scientists 661–670 publications: 8 scientists 671–680 publications: 8 scientists 681–690 publications: 4 scientists 691–700 publications: 3 scientists 701–704 publications: 4 scientists 705+ publications: 100 scientists
31 publications 705+

This scientist: 449 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 705 publications or more.

James T. McCracken D-index placement in Psychology in 2026

The chart shows the D-index (discipline H-index) distribution of Psychology scientists ranked by Research.com in 2026. The highlighted bar marks where James T. McCracken sits on this spectrum.

30–31 D-Index: 398 scientists 32–33 D-Index: 702 scientists 34–35 D-Index: 671 scientists 36–37 D-Index: 659 scientists 38–39 D-Index: 641 scientists 40–41 D-Index: 671 scientists 42–43 D-Index: 617 scientists 44–45 D-Index: 558 scientists 46–47 D-Index: 495 scientists 48–49 D-Index: 487 scientists 50–51 D-Index: 445 scientists 52–53 D-Index: 390 scientists 54–55 D-Index: 408 scientists 56–57 D-Index: 345 scientists 58–59 D-Index: 325 scientists 60–61 D-Index: 321 scientists 62–63 D-Index: 248 scientists 64–65 D-Index: 290 scientists 66–67 D-Index: 218 scientists 68–69 D-Index: 219 scientists 70–71 D-Index: 215 scientists 72–73 D-Index: 183 scientists 74–75 D-Index: 169 scientists 76–77 D-Index: 132 scientists 78–79 D-Index: 137 scientists 80–81 D-Index: 120 scientists 82–83 D-Index: 112 scientists 84–85 D-Index: 86 scientists 86–87 D-Index: 101 scientists 88–89 D-Index: 83 scientists 90–91 D-Index: 77 scientists 92–93 D-Index: 70 scientists 94–95 D-Index: 78 scientists 96–97 D-Index: 58 scientists 98–99 D-Index: 53 scientists 100–101 D-Index: 57 scientists 102–103 D-Index: 48 scientists 104–105 D-Index: 53 scientists 106–107 D-Index: 46 scientists 108–109 D-Index: 24 scientists 110–111 D-Index: 35 scientists 112–113 D-Index: 27 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 31 scientists 118–119 D-Index: 22 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 24 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 11 scientists 128–129 D-Index: 19 scientists 130–131 D-Index: 10 scientists 132–133 D-Index: 16 scientists 134–135 D-Index: 10 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 5 scientists 142–143 D-Index: 12 scientists 144+ D-Index: 98 scientists
30 D-Index 144+

This scientist: 124 D-Index — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 144 D-Index or more.

Overview

James T. McCracken is affiliated with the University of California, Los Angeles in the United States. Their research spans several main fields, including Neuroscience, Medicine, and Psychology. Within these areas, McCracken has made contributions particularly in the subfields of Cognitive Neuroscience, Clinical Psychology, Psychiatry and Mental Health, Radiology, Nuclear Medicine and Imaging, and Genetics.

The primary topics of McCracken's work focus on Autism Spectrum Disorder Research, Obsessive-Compulsive Spectrum Disorders, Attention Deficit Hyperactivity Disorder, Child Nutrition and Feeding Issues, Eating Disorders and Behaviors, Child and Adolescent Psychosocial and Emotional Development, and Advanced Neuroimaging Techniques and Applications.

McCracken has published research in multiple venues. Frequently appearing publication locations include the Journal of the American Academy of Child & Adolescent Psychiatry, Journal of Autism and Developmental Disorders, Journal of Child and Adolescent Psychopharmacology, Biological Psychiatry, and European Neuropsychopharmacology.

Recent research papers by or including McCracken are:

  • Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions, 2021, European Neuropsychopharmacology
  • Exome sequencing in obsessive-compulsive disorder reveals a burden of rare damaging coding variants, 2021, Nature Neuroscience
  • Integrated gene analyses of de novo variants from 46,612 trios with autism and developmental disorders, 2022, Proceedings of the National Academy of Sciences
  • Genome-wide association study of pediatric obsessive-compulsive traits: shared genetic risk between traits and disorder, 2021, Translational Psychiatry
  • Optimizing behavior therapy for youth with Tourette's disorder, 2020, Neuropsychopharmacology

The scientist frequently collaborates with a number of colleagues, including John Piacentini, Eric Hollander, Evdokia Anagnostou, Gerald Nestadt, and Linmarie Sikich.

Best Publications

  • Risperidone in Children with Autism and Serious Behavioral Problems

    James T. McCracken;James McGough;Bhavik Shah;Pegeen Cronin

  • Cognitive Behavioral Therapy, Sertraline, or a Combination in Childhood Anxiety

    John T. Walkup;Anne Marie Albano;John Piacentini;Boris Birmaher

  • Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders

    Phil H. Lee;Verneri Anttila;Hyejung Won;Yen-Chen A. Feng

  • Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis

    Martine Hoogman;Janita Bralten;Derrek P. Hibar;Maarten Mennes

  • Practice Parameter for the Assessment and Treatment of Children and Adolescents With Autism Spectrum Disorder

    Fred Volkmar;Matthew Siegel;Marc Woodbury-Smith;Bryan King

  • Switching to Another SSRI or to Venlafaxine With or Without Cognitive Behavioral Therapy for Adolescents With SSRI-Resistant Depression: The TORDIA Randomized Controlled Trial

    David Brent;Graham Emslie;Greg Clarke;Karen Dineen Wagner

  • Suicide attempts and nonsuicidal self-injury in the treatment of resistant depression in adolescents: findings from the TORDIA study.

    Joan Rosenbaum Asarnow;Giovanna Porta;Anthony Spirito;Graham J Emslie

  • Concurrent validity of the anxiety disorders section of the Anxiety Disorders Interview Schedule for DSM-IV: child and parent versions.

    Jeffrey J. Wood;John C. Piacentini;R. Lindsey Bergman;James McCracken

  • Functional impairment in children and adolescents with obsessive-compulsive disorder.

    John Piacentini;R. Lindsey Bergman;Melody Keller;James McCracken

  • Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning.

    Denis G. Sukhodolsky;Lawrence Scahill;Kenneth D. Gadow;L. Eugene Arnold

  • Catecholamines in attention-deficit hyperactivity disorder: Current perspectives

    Steven R. Pliszka;James T. McCRACKEN;James W. Maas

  • Efficacy and Safety of Immediate-Release Methylphenidate Treatment for Preschoolers with ADHD.

    Laurence Greenhill;Scott Kollins;Howard Abikoff;James Mccracken

  • Revealing the complex genetic architecture of obsessive-compulsive disorder using meta-analysis

    Paul D. Arnold;Kathleen D. Askland;Cristina Barlassina;Laura Bellodi

  • Psychiatric Comorbidity in Adult Attention Deficit Hyperactivity Disorder: Findings From Multiplex Families

    James J. McGough;Susan L. Smalley;James T. McCracken;May Yang

  • Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents

    John T. Walkup;Michael J. Labellarte;Mark A. Riddle;Daniel S. Pine;Daniel S. Pine

  • Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.

    Christopher J Mcdougle;Lawrence Scahill;Michael G. Aman;James T. Mccracken

  • Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism

    Bryan H. King;Eric Hollander;Linmarie Sikich;James T. McCracken

  • Total and regional brain volumes in a population-based normative sample from 4 to 18 years: The NIH MRI study of normal brain development

    W. S. Ball;A. W. Byars;M. Schapiro;W. Bommer

  • Clinical Characteristics of Anxiety Disordered Youth

    Philip C. Kendall;Scott N. Compton;John T. Walkup;Boris Birmaher

  • Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity

    David J. Posey;David J. Posey;Michael G. Aman;L. Eugene Arnold;Yaser Ramadan

  • Genome wide meta-analysis identifies genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders

    Lee Ph;Anttila;Won H

Frequent Co-Authors

John Piacentini
John Piacentini University of California, Los Angeles
James J. McGough
James J. McGough University of California, Los Angeles
Benedetto Vitiello
Benedetto Vitiello University of Turin
Mark A. Riddle
Mark A. Riddle Johns Hopkins University School of Medicine
Christopher J. McDougle
Christopher J. McDougle Harvard University
Michael G. Aman
Michael G. Aman The Ohio State University
Benjamin D. Greenberg
Benjamin D. Greenberg Brown University
Susan L. Smalley
Susan L. Smalley University of California, Los Angeles
Gerald Nestadt
Gerald Nestadt Johns Hopkins University School of Medicine
David L. Pauls
David L. Pauls Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online psychology degrees in the USA opens up a variety of flexible educational and career opportunities. Many students are now considering programs that make it easier to balance studies with other commitments. For those seeking advanced credentials, the easiest online psychology doctorate programs in the US offer accessible options for pursuing high-level roles in research, teaching, or clinical practice.

Master's degrees are also popular pathways, with regionally tailored programs attracting attention. In California, the easiest online psychology master's programs in California allow students to specialize in a diverse and dynamic professional landscape. Similarly, those in the Northeast may consider the easiest online psychology master's programs in Pennsylvania, designed for career advancement in counseling, education, and more.

For students located in central regions, exploring the easiest online psychology degrees in the Midwest provides another avenue to earn respected qualifications without relocating. These online programs are ideal for those aiming to work in areas like social services, mental health, or organizational psychology—all while enjoying the flexibility of remote learning.

Best Scientists Citing James T. McCracken

Trending Scientists

Recently Published Articles